| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Adagio Therapeutics Inc. Common Stock (NASDAQ: ADGI)
ADGI Technical Analysis
5
| As on 14th Nov 2022 ADGI SHARE Price closed @ 3.48 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 15.92 & Strong Sell for SHORT-TERM with Stoploss of 35.82 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ADGISHARE Price
| Open | 3.55 | Change | Price | % |
| High | 3.58 | 1 Day | -0.12 | -3.33 |
| Low | 3.46 | 1 Week | -0.17 | -4.66 |
| Close | 3.48 | 1 Month | 0.35 | 11.18 |
| Volume | 269412 | 1 Year | -17.40 | -83.33 |
| 52 Week High 56.08 | 52 Week Low 2.54 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ADGI Daily Charts |
ADGI Intraday Charts |
Whats New @ Bazaartrend |
ADGI Free Analysis |
|
|
ADGI Important Levels Intraday
| RESISTANCE | 3.71 |
| RESISTANCE | 3.64 |
| RESISTANCE | 3.59 |
| RESISTANCE | 3.55 |
| SUPPORT | 3.41 |
| SUPPORT | 3.37 |
| SUPPORT | 3.32 |
| SUPPORT | 3.25 |
ADGI Forecast April 2024
| 4th UP Forecast | 72.83 |
| 3rd UP Forecast | 50.59 |
| 2nd UP Forecast | 36.84 |
| 1st UP Forecast | 23.09 |
| 1st DOWN Forecast | -16.13 |
| 2nd DOWN Forecast | -29.88 |
| 3rd DOWN Forecast | -43.63 |
| 4th DOWN Forecast | -65.87 |
ADGI Weekly Forecast
| 4th UP Forecast | 16.16 |
| 3rd UP Forecast | 12.09 |
| 2nd UP Forecast | 9.58 |
| 1st UP Forecast | 7.07 |
| 1st DOWN Forecast | -0.11 |
| 2nd DOWN Forecast | -2.62 |
| 3rd DOWN Forecast | -5.13 |
| 4th DOWN Forecast | -9.20 |
ADGI Forecast2024
| 4th UP Forecast | 150.72 |
| 3rd UP Forecast | 103.5 |
| 2nd UP Forecast | 74.31 |
| 1st UP Forecast | 45.12 |
| 1st DOWN Forecast | -38.16 |
| 2nd DOWN Forecast | -67.35 |
| 3rd DOWN Forecast | -96.54 |
| 4th DOWN Forecast | -143.76 |
Adagio Therapeutics Inc. Common Stock ( NASDAQ USA Symbol : ADGI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ADGI Business Profile
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. Its lead product candidate is the ADG20, a neutralizing antibody that is in Phase II/III clinical trials for the treatment and prevention of coronavirus disease. The company has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. Adagio Therapeutics, Inc. was incorporated in 2020 and is based in Waltham, Massachusetts. Address: 303 Wyman Street, Waltham, MA, United States, 02451
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service